2009 Annual Meeting | Criteria for Stopping and Starting Multiple Sclerosis Therapy

好色先生

2009 Annual Meeting | Criteria for Stopping and Starting Multiple Sclerosis Therapy

Date Monday 04/27/09

Time 06:45 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Breakfast Seminar

Director(s) Gary Birnbaum, MD, FAAN

Topic(s)

Learning Objectives Participants should be familiar with some of the variables and difficulties involved in deciding when to start treatment with disease-modifying therapies in RRMS and when to stop such treatments in persons possibly no longer benefiting from them.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident

Event Timeline
06:45 AM - 07:15 AM		When to Start Disease-Modifying Therapy in MS Gary Birnbaum, MD, FAAN
06:45 AM - 08:30 AM		Breakfast
07:15 AM - 07:45 AM		When to Stop Disease-Modifying Therapy in MS Aaron E. Miller, MD, FAAN
07:45 AM - 08:00 AM		Break
08:00 AM - 08:30 AM		Questions and Answers

Faculty Disclosures
Gary Birnbaum, MD, FAAN	No disclosure on file
Aaron E. Miller, MD, FAAN	Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health Services (Caremark). Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corevitas (formerly known as Corrona). Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI=Pharma. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Viatris (Mylan). Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen (Horizon Therapeutics). Dr. Miller has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Sterne Kessler. Dr. Miller has received publishing royalties from a publication relating to health care.